Pulsetto Wins InoPažanga and Secures EU Funding for Innovative Vagus Nerve Stimulator Trials

UAB "Pulsetto" is proud to announce our victory in the prestigious InoPažanga competition, securing European Union funding for our groundbreaking project. This initiative aims to validate the safety and efficacy of our innovative vagus nerve stimulator, Pulsetto, through rigorous clinical trials. Recognizing that clinical trials are crucial for health tech innovation, we are dedicated to ensuring that Pulsetto meets the highest standards, providing customers with reliable, evidence-based technology.

As part of this project, we will dedicate significant efforts to refining the Pulsetto device, developing a functional prototype, and conducting comprehensive clinical trials. These trials will focus on validating the device’s safety and efficacy in reducing stress, alleviating stress-related conditions, and mitigating migraine pain. Additionally, we will produce an initial batch of Pulsetto devices, identifying and correcting any deficiencies to ensure optimal performance.

Upon the project's completion, we will have developed an innovative, high-quality vagus nerve stimulator poised to compete successfully in the market. Our Pulsetto device will be accessible to the public and is expected to significantly enhance the quality of daily life by effectively combating stress and anxiety. Beyond promoting relaxation, Pulsetto will help control inflammatory responses, regulate food intake and feelings of satiety, improve sleep quality, and reduce fatigue. A key outcome of the project is to validate the safety, efficacy, and suitability of the Pulsetto vagus nerve stimulator for treating migraines, depression, cluster headaches, and other conditions during clinical trials.

With the support of the European Union, UAB "Pulsetto" is committed to advancing health technology and improving lives through our innovative solutions.

The project is financed by the European Regional Development Fund.

The duration of the project implementation is 11/14/2023 - 6/10/2026.

The value of the project is 1,307,288.47 EUR

EU funding – 618,022.69 EUR

Administrative institution – Innovation Agency.

More information: www.esinvesticijos.lt